Additionally, microRNA-30e is a negative NLRP3 regulator and its administration exerts neuroprotective effects on murine models with PD, by decreasing the loss of dopaminergic neurons and improving motor and behavioral symptoms [113]. Here, NLRP3 is linked to Parkinson disease.